Treatment of HCV prior to liver transplantation to prevent HCV recurrence – Wise or wasteful?

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|1|9-11

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.1, 2015-01, pp. : 9-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PRO view: treat to prevent recurrence of HCV

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 1, 2015-01 ,pp. : 5-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

P151: Improvement of virologic response and liver elasticity in HCV‐patients after liver transplantation through treatment with the new direct‐acting antivirals

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 94-95

John Wiley & Sons Inc

Access to resources Recommend Favorite

Haemophilia‐related outcome after liver transplantation and treatment with sofosbuvir/ribavirin in a HCV–HIV coinfected man with liver failure and hepatocellular carcinoma

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : e131-e133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Human Monoclonal Antibody MBL‐HCV1 Delays HCV Viral Rebound Following Liver Transplantation: A Randomized Controlled Study

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 4, 2013-04 ,pp. : 1047-1054

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite